Doreen Dileo v. HHS - Influenza, Guillain-Barré Syndrome (2018)
Case summary [AI summaries can sometimes make mistakes]
On December 13, 2016, Doreen Dileo filed a petition for compensation under the National Vaccine Injury Compensation Program. Petitioner alleged that she suffered Guillain-Barré Syndrome (GBS) as a result of an influenza vaccination received on October 22, 2015, and that she experienced residual effects from the GBS for more than six months.
The respondent denied that the vaccination caused petitioner's alleged GBS or any other injury. The parties, maintaining their respective positions, reached a joint stipulation to settle the case.
The stipulation awarded Doreen Dileo a lump sum of $21,814.50, payable by check to the petitioner. This amount represents all damages available under 42 U.S.C. § 300aa-15(a).
Special Master Thomas L. Gowen found the stipulation reasonable and adopted it as the decision of the Court, ordering judgment to be entered in accordance with its terms.
The decision was issued on October 30, 2018. Petitioner was represented by Nancy R.
Meyers, and respondent was represented by Ilene C. Albala.
Theory of causation
Petitioner Doreen Dileo filed a petition on December 13, 2016, alleging Guillain-Barré Syndrome (GBS) following an influenza vaccination on October 22, 2015, with residual effects lasting over six months. Respondent denied causation. The parties entered into a joint stipulation for settlement, agreeing to an award of $21,814.50. Special Master Thomas L. Gowen approved the stipulation on October 30, 2018. The public decision does not describe the specific theory of causation, medical experts, clinical details, onset, symptoms, tests, treatments, or the mechanism of injury. Petitioner's counsel was Nancy R. Meyers, and respondent's counsel was Ilene C. Albala.
Source PDFs
USCOURTS-cofc-1_16-vv-01639